MindMaze Therapeutics Holding S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLFTY research report →
About the company
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play.
- CEO
- Zach Henderson
- IPO
- 2025
- Employees
- 10
- HQ
- Geneva, GE, CH
Price Chart
- Revenue
- $642.00K · -92.37%
- Net Income
- $-9,906,000 · 42.13%
- EPS
- $-0.79 · 42.34%
- Op Income
- $-10,515,000
- FCF YoY
- -134.13%
- 52W High
- $4.05
- 52W Low
- $0.27
- 50D MA
- $0.88
- 200D MA
- $1.62
- Beta
- 2.98
- Avg Volume
- 129
Get TickerSpark's AI analysis on RLFTY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RLFTY coverage
Recent articles, reports, and earnings notes.
No research on RLFTY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RLFTY report →Similar companies
Peers in the same neighborhood.